Advanced 3D Cellular Models

Tuesday, April 16 • 10:30 a.m. – 12:00 p.m.

This track aims to provide an overview of the latest developments in 3D cellular models and explore how they can increase pre-clinical accuracy. The discussions will focus on when and why specific model systems may be used and how they can improve the understanding of diseases and the development of effective drugs.  Attendees will gain an understanding of the use and efficiency of new model systems from experts in the field.

Session Chairs:

Per Setterberg (Iscaffpharma)
Setterberg is the CEO of Iscaffpharma with a professional background in business development, sales and marketing with a demonstrated history of working in the information technology and healthcare industry. He is a member of the board at Direktkonsult and Mevia. Setterberg received a bachelor of economy focused in Economics from the Gothenburg University School of Business and a bachelor of law from Lunds University.

Michelle Vessels (Corning Incorporated)

Speakers:

Moony Tseng, Ph.D. (Broad Institute)

Marc Ferrer, Ph.D. (National Center for Advancing Translational Sciences)
Functional Brain Region-Specific Neural Organotypic Models for Compound Screening

Hoda Zarkoob, Ph.D. (Bristol Myers Squibb)
Leveraging Transwell^® Systems for Enhanced Physiological Relevance and Throughput in Drug Discovery Toxicology Studies